PHARMAC’s decision not to fund melanoma treatment pembrolizumab – marketed as Keytruda – has been widely covered in the media. Public […]
Continue readingcancer
Cancer: the cost of a life – NZH special series
This week the New Zealand Herald has run an extensive five-part series – in print and online – delving deep […]
Continue readingUPDATED: GMO virus approved for cancer trial – Expert reaction
The Environmental Protection Authority (EPA) has approved the use of a genetically modified virus (Pexa-Vec) for a liver cancer treatment trial. The Pexa-Vec virus […]
Continue readingIARC review on red & processed meat – In the News
The release of the International Agency for Research on Cancer (IARC)’s review of meat and cancer risk has dominated the […]
Continue readingWHO report: Red meat linked to cancer – Expert reaction
The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization, has evaluated the links […]
Continue readingIndigenous cancer inequalities compared – In the news
The gap in overall cancer rates between Māori and other New Zealanders is more pronounced than that between indigenous and non-indigenous […]
Continue readingGlobal cancer comparison highlights Maori inequality – Expert reaction
Cancer rates are higher for Maori than other New Zealanders, but the same is not true for other countries’ indigenous […]
Continue readingNew melanoma drug in the headlines
A promising melanoma drug has doctors and patient groups calling for the medicine to be funded by PHARMAC in New […]
Continue readingBowel cancer screening – in the news
The release of a major report on bowel cancer this week has re-ignited debate over nationwide screening for the disease. […]
Continue readingEveryday chemicals could trigger cancer when mixed
Mixtures of common chemicals used in our environment may act in concert with each other in the human body to […]
Continue reading- « Newer posts
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 9
- 10
- Older posts »